Learning Disabilities Research Centers (P50 Clinical Trial Optional)

The Eunice Kennedy ShriverNational Institute of Child Health and Human Development (NICHD) invites center applications for the Learning Disabilities Research Centers Program, hereafter termed LDRCs. The LDRCs initiative focuses on generating new scientific knowledge to inform understanding of specific learning disorders (SLDs) and comorbid conditions through synergistic, integrated, team-based transdisciplinary science. This funding opportunity announcement invites both foundational and translational, transdisciplinary research addressing the definition, classification, etiology, diagnosis, epidemiology, early identification, prevention-based approaches, and remediation of children, adolescents, or young adults identified with or at risk for SLDs in component oral language abilities, reading, written expression abilities, mathematics and relationships among these SLDs and other disabilities and co-occurring or comorbid conditions. The LDRCs provide a unique platform to engage with external research and community members in purposeful, sustained bidirectional communication and provide career enhancing opportunities for early career investigators expanding their reach and impact.

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.